203 related articles for article (PubMed ID: 24771538)
1. Progranulin protein levels are differently regulated in plasma and CSF.
Nicholson AM; Finch NA; Thomas CS; Wojtas A; Rutherford NJ; Mielke MM; Roberts RO; Boeve BF; Knopman DS; Petersen RC; Rademakers R
Neurology; 2014 May; 82(21):1871-8. PubMed ID: 24771538
[TBL] [Abstract][Full Text] [Related]
2. rs5848 polymorphism and serum progranulin level.
Hsiung GY; Fok A; Feldman HH; Rademakers R; Mackenzie IR
J Neurol Sci; 2011 Jan; 300(1-2):28-32. PubMed ID: 21047645
[TBL] [Abstract][Full Text] [Related]
3. Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.
Morenas-Rodríguez E; Cervera-Carles L; Vilaplana E; Alcolea D; Carmona-Iragui M; Dols-Icardo O; Ribosa-Nogué R; Muñoz-Llahuna L; Sala I; Belén Sánchez-Saudinós M; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2016; 50(2):539-46. PubMed ID: 26682689
[TBL] [Abstract][Full Text] [Related]
4. Serum progranulin is not associated with rs5848 polymorphism in Korean patients with neurodegenerative diseases.
Jung NY; Kim HS; Kim ES; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Huh GY; Kim YE; Kim EJ
PLoS One; 2022; 17(1):e0261007. PubMed ID: 35085262
[TBL] [Abstract][Full Text] [Related]
5. Association Between Progranulin and Gaucher Disease.
Jian J; Zhao S; Tian QY; Liu H; Zhao Y; Chen WC; Grunig G; Torres PA; Wang BC; Zeng B; Pastores G; Tang W; Sun Y; Grabowski GA; Kong MX; Wang G; Chen Y; Liang F; Overkleeft HS; Saunders-Pullman R; Chan GL; Liu CJ
EBioMedicine; 2016 Sep; 11():127-137. PubMed ID: 27515686
[TBL] [Abstract][Full Text] [Related]
6. Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.
Meeter LH; Patzke H; Loewen G; Dopper EG; Pijnenburg YA; van Minkelen R; van Swieten JC
Dement Geriatr Cogn Dis Extra; 2016; 6(2):330-340. PubMed ID: 27703466
[TBL] [Abstract][Full Text] [Related]
7. CSF protein changes associated with hippocampal sclerosis risk gene variants highlight impact of GRN/PGRN.
Fardo DW; Katsumata Y; Kauwe JSK; Deming Y; Harari O; Cruchaga C; ; Nelson PT
Exp Gerontol; 2017 Apr; 90():83-89. PubMed ID: 28189700
[TBL] [Abstract][Full Text] [Related]
8. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration.
Rollinson S; Rohrer JD; van der Zee J; Sleegers K; Mead S; Engelborghs S; Collinge J; De Deyn PP; Mann DM; Van Broeckhoven C; Pickering-Brown SM
Neurobiol Aging; 2011 Apr; 32(4):754-5. PubMed ID: 19446372
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma.
Carrasquillo MM; Nicholson AM; Finch N; Gibbs JR; Baker M; Rutherford NJ; Hunter TA; DeJesus-Hernandez M; Bisceglio GD; Mackenzie IR; Singleton A; Cookson MR; Crook JE; Dillman A; Hernandez D; Petersen RC; Graff-Radford NR; Younkin SG; Rademakers R
Am J Hum Genet; 2010 Dec; 87(6):890-7. PubMed ID: 21087763
[TBL] [Abstract][Full Text] [Related]
10. Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency.
Lee WC; Almeida S; Prudencio M; Caulfield TR; Zhang YJ; Tay WM; Bauer PO; Chew J; Sasaguri H; Jansen-West KR; Gendron TF; Stetler CT; Finch N; Mackenzie IR; Rademakers R; Gao FB; Petrucelli L
Hum Mol Genet; 2014 Mar; 23(6):1467-78. PubMed ID: 24163244
[TBL] [Abstract][Full Text] [Related]
11. Progranulin regulates neuronal outgrowth independent of sortilin.
Gass J; Lee WC; Cook C; Finch N; Stetler C; Jansen-West K; Lewis J; Link CD; Rademakers R; Nykjær A; Petrucelli L
Mol Neurodegener; 2012 Jul; 7():33. PubMed ID: 22781549
[TBL] [Abstract][Full Text] [Related]
12. Soluble sortilin is present in excess and positively correlates with progranulin in CSF of aging individuals.
Molgaard S; Demontis D; Nicholson AM; Finch NA; Petersen RC; Petersen CM; Rademakers R; Nykjaer A; Glerup S
Exp Gerontol; 2016 Nov; 84():96-100. PubMed ID: 27612602
[TBL] [Abstract][Full Text] [Related]
13. Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation.
Moreno F; Alzualde A; Camblor PM; Barandiaran M; Van Deerlin VM; Gabilondo A; Martí Massó JF; López de Munain A; Indakoetxea B
Alzheimer Dis Assoc Disord; 2011; 25(1):93-5. PubMed ID: 20711061
[TBL] [Abstract][Full Text] [Related]
14. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
15. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
[TBL] [Abstract][Full Text] [Related]
16. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort.
Antonell A; Gil S; Sánchez-Valle R; Balasa M; Bosch B; Prat MC; Chiollaz AC; Fernández M; Yagüe J; Molinuevo JL; Lladó A
J Alzheimers Dis; 2012; 31(3):581-91. PubMed ID: 22647257
[TBL] [Abstract][Full Text] [Related]
17. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.
Ghidoni R; Benussi L; Glionna M; Franzoni M; Binetti G
Neurology; 2008 Oct; 71(16):1235-9. PubMed ID: 18768919
[TBL] [Abstract][Full Text] [Related]
18. Evidence of the innate antiviral and neuroprotective properties of progranulin.
Suh HS; Lo Y; Choi N; Letendre S; Lee SC
PLoS One; 2014; 9(5):e98184. PubMed ID: 24878635
[TBL] [Abstract][Full Text] [Related]
19. Prosaposin is a regulator of progranulin levels and oligomerization.
Nicholson AM; Finch NA; Almeida M; Perkerson RB; van Blitterswijk M; Wojtas A; Cenik B; Rotondo S; Inskeep V; Almasy L; Dyer T; Peralta J; Jun G; Wood AR; Frayling TM; Fuchsberger C; Fowler S; Teslovich TM; Manning AK; Kumar S; Curran J; Lehman D; Abecasis G; Duggirala R; Pottier C; Zahir HA; Crook JE; Karydas A; Mitic L; Sun Y; Dickson DW; Bu G; Herz J; Yu G; Miller BL; Ferguson S; Petersen RC; Graff-Radford N; Blangero J; Rademakers R
Nat Commun; 2016 Jun; 7():11992. PubMed ID: 27356620
[TBL] [Abstract][Full Text] [Related]
20. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD.
Feneberg E; Steinacker P; Volk AE; Weishaupt JH; Wollmer MA; Boxer A; Tumani H; Ludolph AC; Otto M
J Neural Transm (Vienna); 2016 Mar; 123(3):289-96. PubMed ID: 26659729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
